CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 166 filers reported holding CARA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.69 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $79 | -54.3% | 16,124 | 0.0% | 0.03% | -57.1% |
Q4 2022 | $173 | -99.9% | 16,124 | 0.0% | 0.06% | +14.5% |
Q3 2022 | $151,000 | +2.7% | 16,124 | 0.0% | 0.06% | -3.5% |
Q2 2022 | $147,000 | -25.0% | 16,124 | 0.0% | 0.06% | +29.5% |
Q1 2022 | $196,000 | 0.0% | 16,124 | 0.0% | 0.04% | +76.0% |
Q4 2021 | $196,000 | -21.3% | 16,124 | 0.0% | 0.02% | -40.5% |
Q3 2021 | $249,000 | +8.3% | 16,124 | 0.0% | 0.04% | -41.7% |
Q2 2021 | $230,000 | -61.7% | 16,124 | -73.0% | 0.07% | -73.7% |
Q1 2015 | $600,000 | -24.5% | 59,713 | -25.1% | 0.27% | -9.3% |
Q4 2014 | $795,000 | +5.6% | 79,713 | -11.1% | 0.30% | +23.3% |
Q3 2014 | $753,000 | – | 89,713 | – | 0.24% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RHO CAPITAL PARTNERS INC | 2,799,058 | $42,350,000 | 22.29% |
Chescapmanager LLC | 1,314,603 | $19,890,000 | 2.42% |
Prosight Management, LP | 294,041 | $4,449,000 | 2.06% |
DAFNA Capital Management LLC | 261,442 | $3,956,000 | 1.18% |
Cypress Capital Management LLC (WY) | 81,269 | $1,230,000 | 1.06% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 626,583 | $9,480,000 | 1.02% |
Carmignac Gestion | 1,851,443 | $28,012,000 | 0.29% |
FARALLON CAPITAL MANAGEMENT LLC | 2,465,000 | $37,295,000 | 0.22% |
Ikarian Capital, LLC | 301,700 | $4,565,000 | 0.20% |
DISCIPLINED GROWTH INVESTORS INC /MN | 689,899 | $10,438,000 | 0.20% |